L-Hist Mont Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, formulated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, itching, and rhinorrhea. Montelukast, a leukotriene receptor antagonist, blocks the action of leukotrienes which are inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema. The synergistic effect of these two agents provides comprehensive relief from allergic symptoms by targeting multiple pathways in the allergic inflammatory process. L-Hist Mont is indicated for patients requiring both antihistaminic and leukotriene receptor antagonist therapy, especially in cases where monotherapy is insufficient. It is generally well tolerated, with a low incidence of side effects such as headache, fatigue, and gastrointestinal discomfort. This combination should be used under medical supervision, particularly in patients with hepatic or renal impairment. L-Hist Mont Tablet offers an effective therapeutic option for improving quality of life in individuals suffering from allergic respiratory diseases and related conditions.